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Abstract
Continuous wave EPR power saturation was used to measure electrostatic potentials at spin-labeled sites. Membrane
surface potentials were estimated by power saturating the EPR spectrum of a membrane bound 14 N spin-labeled amphiphile
in the presence of a neutral or positively charged 15N labeled aqueous spin probe. The potentials that are measured are in
good agreement with other probe measurements and with the predictions of the Gouy–Chapman–Stern theory, indicating
that this is a valid approach to determine electrostatic potentials. A spin-labeled affinity probe based on maleimidoben-
zyltrimethylammonium was synthesized and could be derivatized to a sulfhydryl near either agonist site on the nicotinic
acetylcholine receptor. The amplitudes of motion of the spin-probe on the ns time scale are significantly different when the
two labeled sites are compared, and the probe is more restricted in its motion when attached to the more easily labeled site.
When attached to this agonist site, power saturation EPR yields an electrostatic potential of y15 mV. Two other
sulfhydryl-specific probes were used to label this site in reconstituted receptor containing membranes. These probes show
less contact with the receptor and reduced electrostatic potentials, indicating that there is a strong spatial dependence to the
potential at the agonist site. This work demonstrates that power saturation EPR provides a general method that can be used
to estimate electrostatic potentials at any specifically spin-labeled macromolecular site. q 1997 Elsevier Science B.V.
Keywords: Spin labeling; Ligand gated ion channel; Electrostatics; Surface potential; Sulfhydryl probe
1. Introduction
 .The nicotinic acetylcholine receptor AChR is a
ligand-gated ion channel located at the postsynaptic
membrane of the neuromuscular junction. It is com-
posed of five subunits with a stoichiometry of a bdg2
w x1 , with two agonist binding sites one on each a-
subunit. The two agonist binding sites are not equiva-
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lent and there is evidence from covalent labeling and
from cross-linking studies that the acetylcholine bind-
ing sites are located at the a–g and a–d subunit
w xinterfaces 2,3 . Several studies using affinity labeling
have provided evidence that Tyr93, Trp149, Tyr190,
Cys192, Cys193 and Tyr198 from the a-subunit partici-
w xpate in the agonist site 4–6 .
It has been known for some time that there is a
˚readily reducible disulfide bond within 10 A of the
acetylcholine binding site that is formed by Cys192
193 w xand Cys 7,8 . By reducing the receptor with
 .dithiothreitol DTT , the cholinomimetic affinity
 . w3 xreagent 4- N-maleimido benzyltri H methyl ammo-
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 .nium MBTA can be incorporated into one of the
w xacetylcholine binding sites 9 . The only other disul-
fide bonds in the a-subunit are Cys128–Cys142 and
Cys412–Cys418 and they have been shown to be com-
pletely resistant to mild reduction, requiring NaBH4
w xto reduce the disulfide bond 10 . The second site can
be derivatized if labeling is carried out in the pres-
w xence of DTT 11 . Through the use of a cross-linking
reagent, aspartate or glutamate residues that are lo-
˚
192 193cated within 10 A of a Cys rCys have been
identified. These include residues located in the d-
w xsubunit between positions 164–224 3 . Removal of
these negative residues, particularly Asp180 and
Glu189, by site-directed mutagenesis was found to
significantly weaken the affinity of the agonist site
w xfor acetylcholine 12 . Recently, electrostatic poten-
tials were estimated at this site by examining the
w xkinetic salt effect for charged thiosulfonates 13 . The
potentials estimated using this technique were nega-
tive by about 30 mV, consistent with the presence of
acidic residues at the agonist site.
Electrostatic potentials on proteins and membrane
surfaces play crucial roles in the molecular function
w xof biological systems 14,15 , and both computational
and experimental approaches can be taken to investi-
gate their magnitude. One very powerful approach to
estimate macromolecular potentials involves the use
of spin-labeling and electron double resonance
 .ELDOR . In this approach, electrostatic potentials at
a site can be determined by measuring the collisional
frequency between charged or uncharged water-solu-
ble nitroxides and a nitroxide attached to the macro-
w xmolecule 16 . ELDOR provides a measure of the
Heisenberg spin exchange rate, which reflects the
frequency of collisions between paramagnetic species
w x17,18 . This is used to provide a direct measure of
the concentration of the soluble nitroxide. This ap-
proach has a number of advantages over methods that
utilize probe partitioning and it does not suffer from
some difficulties that can be encountered in fluores-
cence measurements. However, this approach re-
quires EPR equipment that is not widely available.
In the present study, we describe the synthesis and
 .characterization of a spin-label I based on the affin-
ity reagent MBTA shown below. We show that this
label can be attached to one or both agonist sites on
the AChR, and we use this label to investigate the
accessibility, and the dynamics of the spin-label at
the two agonist sites. We also demonstrate that con-
tinuous wave power saturation EPR spectroscopy can
be used to measure collisional exchange between 15N
and 14N nitroxide spin labels, and we use this ap-
proach to estimate the electrostatic potential at the
agonist site labeled by probes I, II, III and on
membrane surfaces labeled by the paramagnetic am-
phiphile IV.
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2. Materials and methods
2.1. Materials
 .Egg phosphatidylcholine egg PC and phos-
phatidylserine were obtained from Avanti Polar Lipids
 .Birmingham, AL . Bromoacetylcholine bromide was
synthesized following a procedure described else-
w xwhere 19 . Acrylamide, bis-acrylamide, sodium do-
 .decylsulfate SDS , and Affigel-10 were obtained
 .from BioRad Laboratories Richmond, CA . Mercap-
toethanol, cystamine hydrochloride, iodoacetamide,
 .phenylmethylsulfonylfluoride PMSF , carbamyl-
 .choline, cholic acid, dithiothreitol DTT , glycine,
 .tricine and Trizma were from Sigma St. Louis, MO .
The cholic acid was recrystallized five times from
95% ethanol before use. MOPS was obtained from
 .  .Calbiochem San Diego, CA . Nickel II ethylenedi-
 .aminediacetic acid NiEDDA and N-tempoyl dode-
 .cylamide IV were gifts of Dr. Wayne Hubbell.
 .Nickel acetylacetonate hydrate NiAA and potas-
 .sium chromium oxalate trihydrate CROX , maleic
 .anhydride, N-bromosuccinimide NBS , p-toluidine,
 .benzoyl peroxide, maleimido-proxyl II , maleimi-
 .doethoxyethylcarbamoyl proxyl III , and amino-
tempo were obtained from Aldrich Chemical Co.
 .Milwaukee, WI . p-Toluidine was recrystallized
from 95% ethanol and NBS was recrystallized from
water after filtering solid contaminates. The isotopi-
15  .cally labeled nitroxides, N amino-tempo VI and
15  .N hydroxy-tempo V were obtained from MSD
 .Isotopes Montreal, Canada . Liquid nitrogen frozen
electroplax from Torpedo californica and Torpedo
nobiliana were obtained from Pacific Biomarine,
Venice CA and Biofish Associates, Boston MA, re-
spectively.
2.2. Preparation of phospholipid ˝esicles
To prepare lipid samples of varying surface poten-
tial, chloroform stock solutions of egg PC and PS
were mixed in the appropriate proportion, rotoevapo-
rated and dried overnight in a vacuum desiccator. For
each sample, an appropriate amount of 100 mM KCl,
1 mM MOPS buffer of pH 7.0 was added to the dried
lipid to give a final concentration of approximately
50 mgrml lipid. The lipid was vortexed and the
resulting lipid solution freeze–thawed 6 times. Uni-
lamellar vesicles were formed by passing the lipid
solution through 0.05-mm pore size polycarbonate
 .membrane filters Poretics Corp, Livermore, CA
 .using a Lipofast syringe extruder Avestine, Canada .
Nineteen passes were made through the filters. Vesi-
cles were stored under argon and refrigerated until
used. Lipid concentrations were determined using a
w xmodified Fiske–Subbarrow procedure 20 . The N-
tempoyl dodecylamide spin label was added directly
to the vesicle suspension at a concentration of ap-
proximately 50 mM.
2.3. Preparation of reconstituted AChR membranes
Receptor-rich membranes and reconstituted AChR
 .rAChR samples were prepared from liquid N2
frozen electroplax tissue from T. californica or T.
nobiliana using a procedure described previously
w x21,22 in a lipid mixture consisting of
DOPCrDOPArcholesterol, 63:12:25. The total pro-
tein content of both native and reconstituted mem-
w xbranes was determined as described 23 , and lipid
concentrations were obtained by phosphate assay us-
w xing a modified Fiske–Subbarrow procedure 20 . The
typical lipid : protein ratios used in this sample were
400:1. Gel electrophoresis was performed using the
w xdiscontinuous method 24 , and the rAChR displayed
the four bands corresponding to the four receptor
subunits with a purity that was greater than 95% as
judged by the stain density.
2.4. Synthesis of the MBTA spin label, I
 .A solution of maleic anhydride 1.2 eq in chloro-
form was added slowly to a stirred solution of recrys-
tallized, dry p-toluidine in chloroform. After 1 h, the
 .resulting N- 4-a-methylphenyl maleamic acid crys-
tals were collected and excess maleic anhydride re-
moved by rinsing the crystals with chloroform. Three
 .grams of N- 4-a-methylphenyl maleamic acid was
dissolved in approximately 6 ml of acetic anhydride
containing 500 mg sodium acetate. Cyclization to
 X .4- N -maleimido -toluene was completed by heating
for 30 min. The mixture was poured into ice water,
extracted twice with chloroform and the organic layer
dried by rotory evaporation. Mass spectrometry
yielded the appropriate molecular weight of mrzs
 X187. This product was converted to 4- N -
.maleimido -benzylbromide by refluxing 1.5 g in 30
ml of benzene containing 2.0 g of NBS and 200 mg
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 Xbenzoyl peroxide for 8 h. The product, 4- N -
.maleimido -benzylbromide, was recrystallized in 95%
ethanol and yield an mrzs266 by mass spectrome-
try.
Dimethylamino-tempo was produced by refluxing
1 g of amino-tempo in methanol with the addition of
11 equivalents of 35% formaldehyde for 1 h. To the
mixture, 3.5 equivalents of sodium borohydride was
added and the reaction was allowed to proceed
overnight at room temperature. Water was added to
the mixture and extracted with chloroform. The or-
ganic layer was dried with sodium sulfate and re-
moved under reduced pressure. The dimethylamino-
tempo yielded an mrz of 199. The MBTA analog
was synthesized by reacting 1.2 equivalents of 4-
 X .N -maleimido -benzylbromide with N- dimethyl-
amino-tempo in dry THF for 24 h. The salt precipi-
tate was collected and washed with THF. The MBTA
analog was purified by reverse-phase HPLC on a C18
column using a gradient of 0–80% waterraceto-
nitrile. Fractions were screened by EPR for detection
of a nitroxide. The spin label compound eluted at
38% acetonitrile. The identity of the spin label prod-
uct was confirmed by mass spectrometry which
yielded an mrzs385. The sulfhydryl reactivity of
the label was tested by reacting it with a cysteine
containing peptide, ALCTWFPVL. The spin-labeled
product gave an EPR spectrum that was characteristic
of a nitroxide labeled peptide and the product had the
anticipated value of mrzs1435 as determined by
mass spectrometry.
2.5. Labeling of reconstituted AChR with maleimide
labels
Typically, 1.3 mg of rAChR in buffer A 100 mM
NaCl, 10 mM MOPS, 0.1 mM EDTA, 0.02% sodium
.azide was treated with 20 mM NEM overnight at
48C, in order to block any free sulfhydryls. Excess
NEM was removed by pelleting and resuspending
rAChR vesicles 3 times in a Beckman Airfuge. The
rAChR was then mildly reduced with 500 mM DTT
for 1 h at room temperature. The unreacted DTT was
removed by 3 centrifugation cycles. Spin labels I, II
or III were added to a concentration of 100 mM to
the reduced receptor and allowed to react for 1 h at
room temperature. Free spin label was removed by 3
centrifugation cycles. The washed pellet was typi-
cally resuspended in 10 ml buffer A.
2.6. EPR spectroscopy
EPR measurements were performed using a Varian
E-Line Century Series EPR spectrometer equipped
with an X-band loop-gap resonator. Spectra were
recorded from samples in quartz capillary tubes using
a microwave power of 2 mW and a peak-to-peak
modulation amplitude of 1.6 G. Gas permeable TPX
capillaries were used for the power saturation experi-
ments. Power saturation curves were obtained by
measuring the peak-to-peak amplitude of the first
derivative m s0 EPR line as a function of theI
microwave power in the range of 0.05–70 mW and
plotted against the square root of the microwave
power. The power saturation curves were fitted to the
function:
ye
P
1r2 1reA s IP 1q 2 y1 1 .  .m s0I P1r2
where A is a constant, P is the microwave power1r2
where the first derivative amplitude is reduced to half
its unsaturated value and e is measure of homogene-
w xity of the saturation which varies from 0.5 to 1.5 25 .
As described below, values of P were used to1r2
estimate changes in T , the electron spin-lattice re-1e
laxation time in the presence of other paramagnetic
species.
The paramagnetic metal complex NiEDDA was
used at a concentration of 10 mM unless otherwise
noted. For measurements on lipid bilayers, the un-
charged and charged aqueous 15N spin labels, V and
VI shown below, were used at a concentration of 2
mM. In experiments involving the rAChR, the 15N
spin labels were used at a concentration of 1 mM.
The depth of the alkyl amine nitroxide IV in lipid
bilayers was estimated as described previously by
measuring the effects of oxygen and the paramag-
netic metal complex, NiEDDA on the power satura-
w xtion behavior of the nitroxide 25 .
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2.7. Theory
Heisenberg exchange is a process that occurs when
nitroxides undergo collisions resulting in an exchange
of magnetization between interacting spin pairs. This
is a short-range interaction where the collision radius
˚is on the order of 4 A for the six membered nitrox-
w xides used here 18 . Dipole–dipole interactions can
also take place between nitroxides; however, in non-
viscous media, such as aqueous solutions, Heisenberg
w xexchange is the dominant process 17 . Heisenberg or
spin-exchange with an 15N nitroxide species will
provide an additional relaxation pathway for 14N
nitroxides and will enhance the spin-lattice relaxation
rate, R , of the electron. Following an approach that1e
w xutilized ELDOR spectroscopy 16 , the P value1r2
for one of the 14N spin labels I–III, shown above,
was measured in the presence and absence of one of
the two 15N labels V or VI. These P values were1r2
used to provide an estimate of the local concentration
of the charged and uncharged nitroxide at the 14N
labeled site.
The P value is proportional to the product of1r2
R , the electron spin-lattice relaxation rate, and R ,1 2
the electron spin-spin relaxation rate. In the case
where the electron is being relaxed by a metal ion
with a rapid relaxation rate, the value of DP can1r2
be directly related to W , or the Heisenberg ex-ex
 . w xchange frequency as shown in Eq. 2 26 .
DP AP yP 0 sR R yR0 R0 fR02W 2 .1r2 1r2 1r2 2 1 2 1 2 ex
Here P and P 0 represent the P values in the1r2 1r2 1r2
presence and absence of the paramagnetic species,
respectively, and R0 and R0 represent the spin-lattice1 2
and spin-spin relaxation rates in the absence of the
15N nitroxide. In the present case, the relaxation rate
of the 14N nitroxide is expected to be enhanced by
the presence of the 15N label, and the above approxi-
mation should be appropriate as long as the exchange
rates are small. Because R is expected to be much1
w xmore sensitive to collisions than R 18 , the assump-2
tion will be made that changes in P in the pres-1r2
ence of 15N labels are directly proportional to the
Heisenberg exchange frequency and hence the rate of
collisions between 14N and 15N nitroxide labels.
The potential at a site on a macromolecular surface
at a position r, c , will be related to the concentrationr
of a charged species in the bulk phase, C , and theo
concentration at that site C . Solution non-idealitiesr
will be ignored, which is justified if the ionic envi-
ronments are relatively similar between r and in the
bulk phase. In this case,
zF Cr
C sy ln 3 .r RT Co
where z, F and R have the usual meanings. The
Heisenberg exchange rate, W , between a bound 14Nex
nitroxide and 15N nitroxide species in solution will be
proportional to the concentration of 15N spins. Since
the exchange rate W is expected to be roughlyex
proportional to R for the 14N nitroxide system, the1e
concentration of 15N label at the 14N nitroxide site
will then be proportional to the values of DP , and1r2
we can write:
zF DP z1r2
C sy ln 4 .r 0RT DP1r2
where DP 0 is the value of DP obtained in the1r2 1r2
presence of an uncharged aqueous 15N label and
DP z is the value of DP obtained in the presence1r2 1r2
of a charged aqueous 15N label of valence z.
3. Results
3.1. Co˝alent deri˝atization of the AChR with MBTA-
SL
Shown in Fig. 1A is an EPR spectrum obtained
from a sample of rAChR that was treated with NEM
followed by mild reduction with DTT and labeling
with probe I. Fig. 1B shows the EPR spectrum of an
identical rAChR sample recorded under the same
conditions, except that the mild DTT reduction was
omitted. Relatively little nitroxide is incorporated into
the sample without mild DTT treatment, and NEM
treatment was very effective at blocking any reactive
sulfhydryls. This procedure is believed reduce
Cys192rCys193 and allow access of sulfhydryl reac-
w xtive reagents into this site 9 . The ratio of spin labels
per protein was estimated from the sample protein
concentration by comparing the double integral of the
spectrum shown in Fig. 1A with that for a series of
standard concentrations of I. The nitroxide to protein
ratio was approximately one spin label per protein
( )G.H. Addona et al.rBiochimica et Biophysica Acta 1329 1997 74–84 79
Fig. 1. EPR spectra of rAChR derivatized with the MBTA spin
label. A: labeling of the rAChR following NEM labeling and
DTT treatment. B: no DTT treatment. C: labeling in the presence
of DTT.
consistent with the extent of labeling found for MBTA
under similar conditions. Thus, apparently only one
of the two acetylcholine binding sites was spin la-
beled under these conditions. We did not attempt to
localize the label by sequencing, but previous se-
quencing data on MBTA indicates that it is predomi-
192 w xnantly Cys that is labeled 9 . It is known that
labeling of both a-subunits can be achieved if the
w xalkylation is done in the presence of DTT 11 . To
label both sites with I, the same procedure used for
the spectrum in Fig. 1A was followed, except that the
label was added to a final concentration of 600 mM
in the presence of DTT. The spectrum obtained after
extensive washing of the sample by centrifugation is
shown in Fig. 1C. The EPR spectrum shown in Fig.
1C represents a composite of both the high and low
affinity AChR sites. As is readily apparent by com-
parison with Fig. 1A, motion of the nitroxide on the
ns time scale is substantially greater at this second
site. The sample used to obtain the EPR spectrum in
Fig. 2. EPR spectra of the AChR subunits extracted from SDS
gel slices. Spectra were recorded at comparable spectrometer
settings and provide a relative indication of the levels of spin-
labeling in each subunit.
Fig. 1C was extensively washed until no further
change in the EPR signal was detected, and no free
spin could be detected in the supernatant.
If probe I is selectively incorporated into either
Cys192 or Cys193 only the a-subunit should be la-
beled. To test this prediction, reconstituted AChR
was labeled with I following the protocol used in Fig.
Fig. 3. Power saturation EPR spectra of the MBTA spin-label
analog I, derivatized to the agonist site on the AChR, in the
 .  .presence v and absence ‘ of O . The dashed lines represent2
 .fits to the data using Eq. 1 , and yielded values of P of 6.01r2
and 37.0 mW in the presence of N or 100% O , respectively.2 2
Power saturation of DPPH samples yielded values of P of1r2
approximately 31 mW.
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1A. The protein subunits were resolved by SDS–
PAGE and the EPR spectra for the subunits excised
from the gel were recorded. As seen in Fig. 2, the
only the a-subunit had a measurable level of nitrox-
ide incorporation. Since the only disulfide that be-
comes reduced in the a-subunit under the conditions
used here is the disulfide between Cys192 and Cys193,
the label must reside at one of these positions.
Additional information about the nature of the site
to which the nitroxide is associated can be obtained
using power saturation experiments. Shown in Fig. 3
is a power saturation curve for I in the presence and
absence of O . The DP value obtained from these2 1r2
data is 30.9 mW. When calibrated against a standard
 .sample of DPPH 2,2-diphenyl-1-picryl-hydrazyl ,
which gave a P of 31 mW, this accessibility was1r2
intermediate between values obtained for exposed
nitroxides buried in the hydrocarbon core of mem-
branes and nitroxides that face the aqueous phase
w x27 .
3.2. Co˝alent deri˝atization of the AChR with other
maleimides
In addition to probe I, spectra were also compared
for the purified AChR labeled with the maleimido
proxyl nitroxides, II, and the longer chain probe III.
Even though these probes are not specific for the
agonist site, the only accessible SH groups in purified
AChR under the conditions used here should be the
two cysteines at the agonist site. The EPR spectrum
of rAChR modified with II is shown in Fig. 4A, and
has features that are qualitatively similar to that seen
for probe I. For probe III, Fig. 4B, both a motionally
restricted and more mobile population can be ob-
served; however, the probe is clearly much more
isotropic in its motion when bound to AChR than
either probes I or II. The averaged hyperfine cou-
pling constants for probes I, II and III range from
16.5 to approximately 17 G, close to that usually
obtained for nitroxide probes in an aqueous environ-
w xment 28 . The reciprocal of the central linewidth
resonance DHy1 and the reciprocal of the second0
 2:y1moment of the EPR spectrum, H , provide a
measure of the amplitudes of motion for the nitroxide
side chain on the ns time scale, and can be compared
with the motion of nitroxides incorporated into spe-
w xcific protein sites 29 . From Figs. 1 and 4, the values
 .  .Fig. 4. EPR spectra of the maleimide probes II A and III B
derivatized to reconstituted AChR following the procedure used
in Fig. 1A.
y1  y1.of DH were 0.33, 0.51 and 0.60 G for probes0
 2:y1I, II and III, respectively, while values of H
were 3.68=10y3, 3.70=10y3 and 4.90=10y3, re-
 2:y1spectively. The values of H obtained for probes
I and II are characteristic of nitroxide probes under-
going strong tertiary interactions with the protein
structure, while the value for probe III is characteris-
tic of a nitroxide that has relatively free rotation, such
as that in a flexible loop. The values of DHy10
provide roughly the same information except that by
this measure probe II appears to be similar to probe
III. In spectra that are multicomponent, such as those
 2:y1shown here, the calculation of H emphasizes
motional differences in the broader components, while
DHy1 emphasizes differences in the more isotropic0
w xcomponents 29 . These data indicate that these probes
experience different levels of tertiary contact with the
protein structure, with probe I showing the greatest
level of contact followed in order by probes II and
III.
3.3. Measurement of electrostatic potentials on mem-
brane surfaces using power saturation
In order to determine whether power saturation
EPR can be used to measure electrostatic potentials at
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Table 1
Membrane surface potentials estimated using continuous wave power saturation on extruded unilamellar PCrPS containing membranes a
mol% PS DP Tempo-OH DP Tempo-NH Calculated c Expected c1r2 1r2 3 s s
 .  .  .  .mW mW mV mV
0 0.94 1.18 y5 0
7 1.10 2.65 y23 y17
15 0.81 3.24 y32 y32
25 0.95 4.31 y36 y43
a Based on the reproducibility of the EPR measurements and fitting of the P values, we estimate the error in the calculated surface1r2
potentials to be approximately "20% of the value of the potential, or "5 mV, whichever is greater.
protein spin-labeled sites, measurements of the elec-
trostatic surface potential on a membrane containing
negatively charged lipid were made. These surface
potentials have been extensively characterized using
a number of techniques and are known to be accu-
rately accounted for in the case of monovalent lipids
 . w xby the Gouy–Chapman–Stern GCS model 14 . To
measure the potential using power saturation, the
uncharged 14N alkyl-amide nitroxide label, IV, was
incorporated into extruded vesicles on both mem-
brane surfaces. Using a depth measurement described
w xelsewhere 25 , this nitroxide was found to lie be-
tween the 5-doxyl stearic acid spin-label and the
headgroup, and is therefore well within the mem-
brane interface. Power saturation measurements were
then made in the presence and absence of the un-
charged 15N hydroxytempo, V, and the positively
charged 15N amino-tempo, VI, spin probe. These
probes are membrane permeable and both internal
and external populations of membrane bound spin-
probe see the same concentration of water soluble
probe. It should be noted that the 15N probes contain
a small amount of the 14N isotope. The amplitude due
to this component was corrected by subtraction, but
usually made only a minor change in the estimated
potential 2.
2 One complication encountered in this experiment was the
presence of a small level of 14N spin-labeled nitroxide in the 15N
nitroxide samples. Because of the high concentrations of these
probes, a 99% pure sample produces a measurable intensity in the
central m s0 resonance of the 14N spin-label. In all casesI
examined here, this contribution was never greater than 15% of
the 14N label amplitude. The presence of the 14N signal in the
15N label could be corrected by subtracting the power saturation
curve for the 14N signal in the absence of the 14N probe. This
correction changed the estimate of the membrane surface poten-
tial by at most 5–10% in the cases examined here.
Shown in Table 1 are the DP values for probe1r2
IV produced by addition of 2 mM 15N hydroxy-tempo
and 2 mM 15N amino-tempo. In the absence of any
added PS, the two labels produce approximately the
same change in the power saturation behavior of the
membrane bound 14N label within experimental error.
This is expected because the two labels have the
same size and the PC membrane surface is un-
charged. As the membrane charge density is in-
creased, the effect of the uncharged label V remains
nearly the same, while the DP value for the1r2
positively charged probe VI increases. This increase
in DP is a result of an enhanced collision fre-1r2
quency of the 15N label with the membrane bound
14N label, producing an enhancement in the T of1e
 .the bound nitroxide. Using Eq. 4 an experimental
estimate of c was obtained and is also shown ins
Table 1. Comparison with the values of c predicteds
by the Gouy–Chapman–Stern model with the experi-
mental estimate shows generally good agreement and
indicates that this is a valid approach to estimate
membrane surface potentials.
3.4. Estimate of the electrostatic potential near the
agonist site
Using the procedure described above, electrostatic
potentials on the AChR were measured at the posi-
tions of probes I, II and III from the values of DP1r2
obtained in the presence of V or VI. Table 2 shows
the values for DP obtained in the presence of 15N1r2
hydroxy-tempo and 15N amino-tempo for rAChR in
EPC labeled with I at an ionic strength of about 100
 .mM. From Eq. 4 , the calculated potential is y15.8
mV. Also shown in Table 2 are the DP values for1r2
probes II and III covalently derivatized to the AChR
in the presence of probes V or VI. These probes
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Table 2
Potentials at the AChR agonist site estimated using continuous wave power saturation
Probe DP Tempo-OH DP Tempo-NH Estimated c1r2 1r2 3 s
 .  .  .mW mW mV
 .I MBTA-SL 8.1 15.22 y15.8
II 3.8 4.9 y5.9
III 4.0 4.0 0.0
a 15N amino-tempo and 15N hydroxy-tempo were used at a concentration of 1 mM.
produce a substantially lower estimate of the poten-
tial at the labeled site.
4. Discussion
The EPR spectra of the MBTA analog I shown in
Fig. 1 indicates that the two agonist sites on the
AChR are non-equivalent, and that the label when
bound to the second site is less constrained and
undergoing less contact with the protein structure
than in site 1. The reasons for this difference are not
clear, but must result from a larger volume available
to the probe when derivatized to the second site. That
these two sites are different is not surprising, the sites
are believed to reside at two non-equivalent subunit
w xinterfaces 2,3 , they show differences in their affinity
towards toxins, and Cys192 and Cys193 are more
w xdifficult to reduce in site 2 11 . When bound to the
‘easily’ labeled site, site 1, the spectrum is character-
istic of a nitroxide that is undergoing strong tertiary
contact with the protein structure. The spectrum
clearly shows evidence for two components as do the
maleimide labels II and III. These two components
could be due to labeling at the two cysteine positions,
two different conformations of the receptor, or differ-
ent conformeric forms of the probe. There is prece-
dence for this later possibility as sulfhydryl-specific
nitroxide probes that can exist in several conformeric
w xforms show similar types of spectra 29 . Previous
work on the maleimide spin label II in native AChR
containing membranes also showed evidence for mul-
w xtiple populations of label 30,31 ; however, both the
AChR and the peripheral 43-kDa protein were la-
beled and the heterogeneity in this case was at-
tributed to non-specific labeling of reduced disul-
 .fides. In the present case, see Section 3: Results
there is little non-specific labeling of the rAChR and
this does not appear to be the appropriate explanation
for the lineshapes shown here.
From the lineshapes, the nitroxide of the MBTA
analog I appears to be in stronger contact with the
receptor than either maleimide labels II or III. This is
not unexpected as probe I should be a good analog
for the agonist site. The spectrum of probe III is
significantly more isotropic and shows less evidence
for association with the protein than either probes I
or II. This is an indication that this probe is extended
from the agonist site. The linker in probe III would
˚allow it to extend an additional 6–7 A compared to
the maleimide probe II.
In the present study, we used power saturation
EPR spectroscopy to determine electrostatic poten-
tials at negatively charged membrane surfaces and at
the agonist site on the AChR reconstituted into vesi-
cles. In lipid bilayers, the local concentration of 15N
labeled nitroxides can be effectively probed by exam-
ining the power saturation behavior of 14N nitroxide
labels, and the DP values used to estimate the1r2
membrane surface potential. Because the membrane
surface potential has been so well characterized
w x14,32–34 , it provides an excellent test for the ap-
proach and assumptions made here. For example,
under the conditions used here 15N labels are treated
in a similar fashion to fast relaxing paramagnetic
metals. The good agreement between the expected
and measured potentials is a strong indication that for
the conditions and potential range examined here
these approximations are valid. It should be noted
that this approach is not restricted to measurements
of the membrane surface potential. In principle, this
measurement could also be applied to the measure-
ment of other membrane electric fields such as the
dipole potential. In the case of the dipole potential,
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measurements of the collisional frequency with
charged species that cross the interface would permit
an estimate of this potential.
The MBTA nitroxide analog I reported a potential
of about y15"3 mV at one of the agonist sites on
the receptor, consistent with the proposed presence of
negatively charged amino acid side chains at the
w xagonist site 12 . This estimate is less than the value
of y30 mV reported by measuring the kinetic salt
w xeffect of charged methanethiosulfonates 13 . That
these measurements are different is not surprising as
the nitroxide on probe I is not located at the same
position as Cys192 or Cys193; in addition, probe I also
introduces an additional positive charge into the bind-
ing site. What is somewhat surprising is that the
maleimide probe II reported less of a potential than
probe I, and that probe III also reported no signifi-
cant electrostatic potential. Probe I appears to interact
most strongly with the agonist site followed by probes
II and III, as indicated both by the values of DHy10
and the second moments of the spectra. Thus, the
magnitudes of the electrostatic potentials appear to
correlate with the interactions made by these labels.
We speculate that the electrostatic potential at the
agonist site exhibits significant spatial dependence,
and that differences in these probes are a result of the
different positions they occupy. At 100 mM ionic
˚strength, the Debye length is approximately 10 A.
Given the size of these probes and possible distance
from either Cys192 or Cys193, this variation in electro-
static potential is not unreasonable.
It should be noted that the measurement of an
electrostatic potential at these protein sites presumes
that differences in the interactions of the soluble
nitroxides V and VI with the protein bound nitrox-
ides are entirely the result of electrostatics. Although
these two probes are of virtually identical size, the
measured potentials will not be accurate if there are
significant differences in the steric interactions that
these probes make with the binding site. The relax-
ation process measured here should be dominated by
a contact or Heisenberg exchange, a process that
˚takes place when nitroxides are separated by 4–5 A.
However, these probes clearly have some motion,
and the potential that they sense will clearly be a
spatial average of the conformations executed by the
bound nitroxide label.
In conclusion, electrostatic potentials can be esti-
mated at macromolecular surfaces by the use of
continuous wave power saturation EPR. On mem-
brane surfaces, these potentials are in agreement with
other methods and with the predictions of the Gouy–
Chapman–Stern theory. Using this approach, the
electrostatic potential near the agonist site of the
nicotinic acetylcholine receptor was estimated using a
spin-labeled affinity probe I based on MBTA. The
probe detected a small negative potential at this site,
consistent with previous measurements and with the
expected amino acid composition at the site. Two
other sulfhydryl-specific probes were tested that show
less contact with the protein and reported reduced
electrostatic potentials. This likely reflects the spatial
dependence of the potential at the agonist site.
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